Zobrazeno 1 - 10
of 31
pro vyhledávání: '"A. S. Gudymo"'
Autor:
V. A. Evseenko, A. V. Zaykovskaya, A. S. Gudymo, O. S. Taranov, S. E. Olkin, A. R. Imatdinov, E. Yu. Prudnikova, N. V. Danilchenko, I. S. Shulgina, M. N. Kosenko, E. I. Danilenko, S. A. Pyankov, A. B. Ryzhikov
Publikováno v:
Биопрепараты: Профилактика, диагностика, лечение, Vol 23, Iss 4, Pp 530-543 (2023)
Scientific relevance. The use of recombinant antigens in vaccine production is limited because vaccines based on such antigens tend to have low immunogenicity. However, a COVID-19 vaccine that combines recombinant SARS-CoV-2 spike glycoprotein as its
Externí odkaz:
https://doaj.org/article/04f5c47f181c475a88f4a2d66be91651
Autor:
V. A. Evseenko, A. S. Gudymo, N. V. Danilchenko, S. V. Svyatchenko, O. S. Taranov, A. B. Ryzhikov
Publikováno v:
Биопрепараты: Профилактика, диагностика, лечение, Vol 22, Iss 2, Pp 170-186 (2022)
The COVID-19 pandemic has exacerbated the public’s need for effective vaccines. Consequently, significant financial support has been provided to developers of a number of innovative vaccines, including the vaccines with saponin-based adjuvants. In
Externí odkaz:
https://doaj.org/article/a14d6cc495894191ab2057476c36a421
Autor:
A. B. Ryzhikov, Е. А. Ryzhikov, M. P. Bogryantseva, S. V. Usova, E. D. Danilenko, E. A. Nechaeva, O. V. Pyankov, O. G. Pyankova, A. S. Gudymo, S. A. Bodnev, G. S. Onkhonova, E. S. Sleptsova, V. I. Kuzubov, N. N. Ryndyuk, Z. I. Ginko, V. N. Petrov, A. A. Moiseeva, P. Yu. Torzhkova, S. A. Pyankov, T. V. Tregubchak, D. V. Antonec, E. V. Gavrilova, R. A. Maksyutov
Publikováno v:
Инфекция и иммунитет, Vol 11, Iss 2, Pp 283-296 (2021)
Vaccination of the population is one of the most effective countermeasures in responding to the pandemic caused by novel coronavirus infection. Therefore, scientists all over the world have been working to develop effective and safe vaccines. We have
Externí odkaz:
https://doaj.org/article/7df779e259364aabaefcf269dea25ef1
Autor:
S. V. Svyatchenko, A. G. Durymanov, N. P. Kolosova, A. S. Gudymo, N. I. Goncharova, P. Yu. Torzhkova, Yu. A. Bulanovich, A. V. Epanchintseva, A. V. Danilenko, V. Yu. Marchenko, A. V. Sysoeva, I. M. Susloparov, T. V. Tregubchak, A. B. Ryzhikov, R. A. Maksyutov, T. N. Ilicheva
Publikováno v:
Журнал микробиологии, эпидемиологии и иммунобиологии, Vol 0, Iss 4, Pp 58-64 (2019)
Aim. Evaluation of herd immunity prior to the 2017-2018 influenza season, and characterization of influenza viruses isolated from severe or fatal influenza cases and from influenza cases in people vaccinated in the fall of 2017. Materials and methods
Externí odkaz:
https://doaj.org/article/bb09fe220ce34c49a96472ad1e9751f8
Autor:
A. S. Gudymo, S. V. Maltsev, V. A. Evseenko, N. V. Danilchenko, V. Y. Marchenko, A. G. Durymanov, A. B. Ryzhikov
Publikováno v:
Биопрепараты: Профилактика, диагностика, лечение, Vol 17, Iss 4, Pp 233-239 (2018)
The article describes the first attempt to use the juice and extract of Cyclamen europaeum (Cyclamen purpurascens) tubers as an adjuvant for intranasal immunization of mice with influenza antigens. The concentration of antigens used for immunization
Externí odkaz:
https://doaj.org/article/4210d4b2bc6044cba00c50f4883fdc8e
Autor:
Victor A. Svyatchenko, Vladimir A. Ternovoi, Roman Y. Lutkovskiy, Elena V. Protopopova, Andrei S. Gudymo, Nataliya V. Danilchenko, Ivan M. Susloparov, Nataliya P. Kolosova, Alexander B. Ryzhikov, Oleg S. Taranov, Vladimir V. Omigov, Elena V. Gavrilova, Alexander P. Agafonov, Rinat A. Maksyutov, Valery B. Loktev
Publikováno v:
Microorganisms; Volume 11; Issue 1; Pages: 180
In this study, we investigated the features of the infectious process by simulating co-infection with SARS-CoV-2 and human adenovirus type 5 (HAdV-5) or influenza A virus (IAV) in vitro and in vivo. The determination of infectious activity of viruses
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e14ff165315f8d94bc0f31084d14c486
Autor:
Natalia P. Kolosova, Tatiana N. Ilyicheva, Vasily V. Unguryan, Alexey V. Danilenko, Svetlana V. Svyatchenko, Galina S. Onhonova, Natalia I. Goncharova, Maksim N. Kosenko, Andrey S. Gudymo, Vasiliy Y. Marchenko, Alexander N. Shvalov, Ivan M. Susloparov, Tatiana V. Tregubchak, Elena V. Gavrilova, Rinat A. Maksyutov, Alexander B. Ryzhikov
Publikováno v:
Pathogens; Volume 11; Issue 11; Pages: 1388
The circulation of seasonal influenza in 2020–2021 around the world was drastically reduced after the start of the COVID-19 pandemic and the implementation of mitigation strategies. The influenza virus circulation reemerged in 2021–2022 with the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::774b1c3ce61c4fb3d239a6801ded32c3
Autor:
Marina P. Bogryantseva, Evgenii А. Ryzhikov, Polina Yu Torzhkova, Denis V. Antonets, Natal’ya V Danil’chenko, Ivan M. Susloparov, Нечаева Елена Августовна (Ru), Galina S. Onkhonova, T. V. Tregubchak, Stepan A. Pyankov, Andrei S. Gudymo, Aleksandr B Ryzhikov, Ilnaz R. Imatdinov, Rinat A. Maksyutov, E. D. Danilenko, Sergei A. Bodnev, Elena V. Gavrilova, Ekaterina S. Sleptsova, Anastasiya A. Moiseeva, Vladimir N. Petrov, Olga G. Pyankova, Oleg V. Pyankov, Oleg S. Taranov, E. A. Nechaeva
Publikováno v:
Annals of the Russian academy of medical sciences. 76:5-19
Background: In 2020, the pandemic caused by novel coronavirus infection has become one of the most critical global health challenges during the past century. The lack of a vaccine, as the most effective way to control the novel infection, has prompte
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::697278b8262a88fca979f7c5b6c75ae6
https://doi.org/10.15690/vramn1528
https://doi.org/10.15690/vramn1528
Autor:
E. A. Nechaeva, Z. I. Ginko, S. V. Usova, T. V. Tregubchak, Е. А. Ryzhikov, Andrei S. Gudymo, Rinat A. Maksyutov, E. S. Sleptsova, Marina P. Bogryantseva, A. A. Moiseeva, E. D. Danilenko, Oleg V. Pyankov, N. N. Ryndyuk, P. Yu. Torzhkova, Olga G. Pyankova, Elena V. Gavrilova, Galina S. Onkhonova, D. V. Antonec, Alexander B. Ryzhikov, V. I. Kuzubov, Sergei A. Bodnev, Stepan A. Pyankov, V. N. Petrov
Publikováno v:
Infekciâ i Immunitet, Vol 11, Iss 2, Pp 283-296 (2021)
Vaccination of the population is one of the most effective countermeasures in responding to the pandemic caused by novel coronavirus infection. Therefore, scientists all over the world have been working to develop effective and safe vaccines. We have
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e8c10ef0ef4e781f89cac1b70b17f234
https://doi.org/10.15789/2220-7619-asb-1699
https://doi.org/10.15789/2220-7619-asb-1699
Autor:
Alexander B. Ryzhikov, Evgeny A. Ryzhikov, Marina P. Bogryantseva, Svetlana V. Usova, Elena A. Nechaeva, Elena D. Danilenko, Stepan A. Pyankov, Andrey S. Gudymo, Anastasiya A. Moiseeva, Galina S. Onkhonova, Oleg V. Pyankov, Ekaterina S. Sleptsova, Nikita V. Lomakin, Veronika S. Vasilyeva, Mikhail V. Tulikov, Vitaly G. Gusarov, Andrey A. Pulin, Maria A. Balalaeva, Svetlana B. Erofeeva, Stanislav A. Terpigorev, Olga A. Rychkova, Ivan M. Petrov, Viktoriia Y. Delian, Vladimir V. Rafalskiy, Sergey V. Tyranovets, Elena V. Gavrilova, Rinat A. Maksyutov
Publikováno v:
Vaccines; Volume 11; Issue 5; Pages: 998
The State Research Center of Virology and Biotechnology “VECTOR” of the Federal Service for the Oversight of Consumer Protection and Welfare (Rospotrebnadzor) has developed the peptide-based EpiVacCorona vaccine, which is the first synthetic pept
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bc4c1bf88ba41a793fdf3099def46351
https://doi.org/10.3390/vaccines11050998
https://doi.org/10.3390/vaccines11050998